The pathology of diabetic neuropathy and the effects of aldose reductase inhibitors.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D001341:Autonomic Nervous System / Q000473:pathology; D001369:Axons / Q000648:ultrastructure; D001786:Blood Glucose; D003238:Connective Tissue / Q000473:pathology; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000473:pathology*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007294:Inositol / Q000627:therapeutic use; D008854:Microscopy, Electron; D009422:Nervous System Diseases / Q000473:pathology; D012677:Sensation; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*; D013497:Sural Nerve / Q000473:pathology
D001786:Blood Glucose; D004791:Enzyme Inhibitors; D007294:Inositol; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase